New concise, direct synthesis pathway to potential medicines created

Image
ANI Washington
Last Updated : May 10 2015 | 2:48 PM IST

A team of chemists has discovered a new chemical reaction called "metallacycle-mediated cross-coupling" that has the potential to facilitate the search for pharmaceutical drugs.

Organic synthesis is a scientific discipline central to the drug discovery process that is focused on building new carbon-based molecules that can affect biology, for example, targeting and destroying cancer cells.

In the study, the Dartmouth College authors describe a new chemical reaction that converts simple starting materials into architecturally complex molecules called "decalins" in a single step. Decalins are carbon-based compounds containing two hexagon rings.

Co-author Glenn Micalizio said that the findings are noteworthy not only because this chemical reaction simplifies the laboratory preparation of such species, but also because our study reveals a unique mode of reactivity associated with metal-carbon bonds that are embedded in complex carbon-based structures.

Micalizio noted that general species of the type studied here have previously been thought to be fleeting intermediates whose reactivity was difficult to control, adding that an important part of this paper demonstrates our ability to reveal new reactivity patterns of these species, prompting them to engage in highly selective chemical transformations.

This latest finding provides a concise and direct synthesis pathway that, due to the structure of the products delivered, will likely be quite valuable for the discovery and development of therapeutic agents, added Micalizio.

The findings appear in the Journal of the American Chemical Society.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 10 2015 | 2:39 PM IST

Next Story